NO20034741L - Anvendelse av desoksypeganin for behandling av sykdomsforeteelser i det sentrale nervesystem grunnet forgiftning med psykotropiske substanser - Google Patents

Anvendelse av desoksypeganin for behandling av sykdomsforeteelser i det sentrale nervesystem grunnet forgiftning med psykotropiske substanser

Info

Publication number
NO20034741L
NO20034741L NO20034741A NO20034741A NO20034741L NO 20034741 L NO20034741 L NO 20034741L NO 20034741 A NO20034741 A NO 20034741A NO 20034741 A NO20034741 A NO 20034741A NO 20034741 L NO20034741 L NO 20034741L
Authority
NO
Norway
Prior art keywords
deoxypeganine
treatment
medicines
substances
poisoning
Prior art date
Application number
NO20034741A
Other languages
English (en)
Other versions
NO20034741D0 (no
Inventor
Klaus Opitz
Joachim Moormann
Thomas Hille
Frank Becher
Original Assignee
Hf Arzneimittelforsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7682410&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20034741(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh
Publication of NO20034741L publication Critical patent/NO20034741L/no
Publication of NO20034741D0 publication Critical patent/NO20034741D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Oppfinnelsen er rettet mot anvendelse av deoksypeganin, som fri base eller syre addisjonssalt, for behandling av cerebrale, sentralnerve eller psykiatriske symptomer, defunksjonalisering manifestasjoner eller forstyrrelser som forekommer gjennom inntak av psykotropiske substanser, som en konsekvens av tilfeldig eller kronisk misbruk av vanedannende substanser, rusmidler eller medisiner, eller som sideeffekt av bruk, særlig gjentatt eller forlenget, som beregnet som medikamenter, eller som en effekt av bruk, særlig gjentatt eller forlenget, av medikamenter, hvilken bruk ikke er tilsiktet bruk av nevnte medikamenter, eller som et resultat av akutt forgiftning med psykotropisk toksiske substanser, eller som et resultat av kronisk eksponering for psykotropisk aktive toksiske substanser i mennesker eller andre vertebrater.
NO20034741A 2001-04-24 2003-10-23 Anvendelse av desoksypeganin for behandling av sykdomsforeteelser i det sentrale nervesystem grunnet forgiftning med psykotropiske substanser NO20034741D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10119863A DE10119863A1 (de) 2001-04-24 2001-04-24 Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen
PCT/EP2002/004278 WO2002087553A2 (de) 2001-04-24 2002-04-18 Verwendung von desoxypeganin zur behandlung von krankheitserscheinungen des zentralen nervensystems aufgrund von intoxikationen mit psychotropen substanzen

Publications (2)

Publication Number Publication Date
NO20034741L true NO20034741L (no) 2003-10-23
NO20034741D0 NO20034741D0 (no) 2003-10-23

Family

ID=7682410

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034741A NO20034741D0 (no) 2001-04-24 2003-10-23 Anvendelse av desoksypeganin for behandling av sykdomsforeteelser i det sentrale nervesystem grunnet forgiftning med psykotropiske substanser

Country Status (28)

Country Link
US (1) US20040132751A1 (no)
EP (1) EP1383503B1 (no)
JP (1) JP2004526791A (no)
KR (1) KR20030094365A (no)
CN (1) CN1638774A (no)
AR (1) AR033469A1 (no)
AT (1) ATE411024T1 (no)
AU (1) AU2002325209B2 (no)
BR (1) BR0209125A (no)
CA (1) CA2445132C (no)
CZ (1) CZ20032788A3 (no)
DE (2) DE10119863A1 (no)
DK (1) DK1383503T3 (no)
EA (1) EA200301134A1 (no)
ES (1) ES2316595T3 (no)
HK (1) HK1062402A1 (no)
HU (1) HUP0303921A3 (no)
IL (1) IL158383A0 (no)
MX (1) MXPA03009766A (no)
MY (1) MY135676A (no)
NO (1) NO20034741D0 (no)
NZ (1) NZ529005A (no)
PL (1) PL366845A1 (no)
PT (1) PT1383503E (no)
SI (1) SI1383503T1 (no)
SK (1) SK287214B6 (no)
WO (1) WO2002087553A2 (no)
ZA (1) ZA200308042B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10354894A1 (de) * 2003-11-24 2005-07-07 Hf Arzneimittelforschung Gmbh Orale Formulierungen des Desoxypeganins und deren Anwendungen
DE10354893B4 (de) * 2003-11-24 2011-03-10 Hf Arzneimittelforschung Gmbh Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen
ES2360547B1 (es) * 2009-11-02 2012-07-04 Consejo Superior De Investigaciones Científicas (Csic) Procedimiento de obtención de los alcaloides activos de la planta medicinal peganum harmala y su uso.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US4031894A (en) * 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
DE3843239C1 (no) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
US5602184A (en) * 1993-03-03 1997-02-11 The United States Of America As Represented By Department Of Health And Human Services Monoterpenes, sesquiterpenes and diterpenes as cancer therapy
DE19906978B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit
DE19906975B4 (de) * 1999-02-19 2004-04-15 Lts Lohmann Therapie-Systeme Ag Arzneiform zur Behandlung von Alzheimer'scher Demenz
DE19906979B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit
DE19906974C2 (de) * 1999-02-19 2003-10-09 Lohmann Therapie Syst Lts Verwendung von Desoxypeganin zur Behandlung des Alkoholismus
DE19906977C1 (de) * 1999-02-19 2000-06-15 Lohmann Therapie Syst Lts Desoxypeganin-TTS und seine Verwendung
DE19924951B4 (de) * 1999-05-31 2004-02-05 Lts Lohmann Therapie-Systeme Ag Verwendung von Desoxypeganin zur Prophylaxe bzw. Vorbehandlung einer Vergiftung durch phosphororganische Cholinesterasehemmer
EP1231877A4 (en) * 1999-11-04 2009-03-18 Xel Herbaceuticals TRANSDERMALE ADMINISTRATION OF HUPERZIN

Also Published As

Publication number Publication date
DE50212901D1 (de) 2008-11-27
SI1383503T1 (sl) 2009-04-30
AU2002325209B2 (en) 2007-08-16
NZ529005A (en) 2007-11-30
WO2002087553A2 (de) 2002-11-07
MXPA03009766A (es) 2005-04-19
DE10119863A1 (de) 2002-11-07
ES2316595T3 (es) 2009-04-16
CN1638774A (zh) 2005-07-13
IL158383A0 (en) 2004-05-12
ATE411024T1 (de) 2008-10-15
BR0209125A (pt) 2004-07-27
EP1383503B1 (de) 2008-10-15
AR033469A1 (es) 2003-12-17
PL366845A1 (en) 2005-02-07
JP2004526791A (ja) 2004-09-02
EA200301134A1 (ru) 2004-04-29
CA2445132C (en) 2009-01-13
SK287214B6 (sk) 2010-03-08
HUP0303921A3 (en) 2011-03-28
DK1383503T3 (da) 2009-02-16
KR20030094365A (ko) 2003-12-11
HK1062402A1 (en) 2004-11-05
PT1383503E (pt) 2009-01-07
EP1383503A2 (de) 2004-01-28
HUP0303921A2 (hu) 2004-03-01
ZA200308042B (en) 2004-02-04
CA2445132A1 (en) 2002-11-07
SK13162003A3 (sk) 2004-02-03
CZ20032788A3 (en) 2004-05-12
NO20034741D0 (no) 2003-10-23
US20040132751A1 (en) 2004-07-08
MY135676A (en) 2008-06-30
WO2002087553A3 (de) 2003-02-27

Similar Documents

Publication Publication Date Title
AR109590A2 (es) Régimen posológico para inhibidores de comt
BRPI0518266B8 (pt) medicamento oral de liberação modificada de pelo menos um princípio ativo sob a forma multimicrocapsular
BR9908488A (pt) Composição farmacêutica de topiramato
PT1066036E (pt) Agentes com actividade relacionada com serotonina para o tratamento da apneia do sono
BR0008447A (pt) Métodos de tratamento de distúrbios mitocondriais
MX2007008227A (es) Prevencion de trastornos tromboticos con compuestos de vitamina d activa o mimeticos de los mismos.
BR9811093A (pt) Piridinas substituìdas com 2-amino-6-(4-fenóxi 2-substituìdo)
FI911700A0 (fi) Anvaendning av n-alkylerade 1,4 -dihydropyridinkarboxylsyraestrar som laekemedel, nya foereningar och foerfarande foer deras framstaellning.
BR9811921A (pt) Aminopiridinas alcóxi-substituìdas ramificadas como inibidores de sintase de óxido nìtrico (nos)
PT1425005E (pt) Composicao farmaceutica que compreende lumiracoxib
CY1113488T1 (el) Ενα φαρμακο για την δυο βαθμιδων περιεγχειρητικη θεραπεια συμπαγων ογκων δια ραδιοανοσοθεραπειας
NO20034741L (no) Anvendelse av desoksypeganin for behandling av sykdomsforeteelser i det sentrale nervesystem grunnet forgiftning med psykotropiske substanser
BR0010006A (pt) Utilização do saredutante e de seus sais farmaceuticamente aceitáveis para o preparo de medicamentos úteis no tratamento ou na prevenção do conjunto das perturbações do humor, das perturbações da adaptação ou das perturbações mistas ansiedade-depressão
NO953892L (no) Imidazolokinoksalinon-derivater som EAA-antagonister
BRPI0407438A (pt) Sistema terapêutico compreendendo amoxicilina e ácido clavulânico
CY1110368T1 (el) Συνεργιστικος συνδυασμος ο οποιος περιλαμβανει ροφλουμιλαστη και (r,r)-φορμοτερολη
HUP0401123A2 (hu) Galantamin alkalmazása a központi idegrendszer kóros tüneteinek kezelésére pszichotróp anyagokkal történő mérgezés esetén
Angley et al. Children and autism: Part 2-management with complementary medicines and dietary interventions
RU94032792A (ru) Применение 5нтiа - антагонистов для прекращения использования табака
Andrès et al. Review of oral vitamin B12 (cobalamin) therapy
WO2006121943A3 (en) Method for the treatment of magnesium and potassium deficiencies
JP2004526791A5 (no)
TH124101B (th) องค์ประกอบที่ประกอบด้วยโมแดฟินิลสำหรับการรักษาแอทเทนชัน เดฟิซิท ไฮเปอร์แอกทิวิตี้ ดิสออร์เดอร์และความล้าเหตุมัลติเพิลสคลีโรซีส
KR970702037A (ko) 지발성 디스키네시아의 치료용 의약 조성물과 이의 용도 기술분야
RU2001110905A (ru) Способ лечения критической ишемии нижних конечностей